 | • レポートコード：GIR-107A14781 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トゥレット症候群治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トゥレット症候群治療薬の種類別市場規模（AZD-5213、CPP-115、デュテトラベナジンER、塩酸エコピパム、その他）、用途別市場規模（研究センター、病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トゥレット症候群治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abide Therapeutics Inc、Catalyst Pharmaceuticals Inc、Neurocrine Biosciences Inc、Psyadon Pharmaceuticals Inc、Reviva Pharmaceuticals Inc、Synchroneuron Inc、Teva Pharmaceutical Industries Ltd、Therapix Biosciences Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AZD-5213、CPP-115、デュテトラベナジンER、塩酸エコピパム、その他 ・用途別分析2016年-2026年：研究センター、病院、クリニック、その他 ・トゥレット症候群治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トゥレット症候群治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トゥレット症候群治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トゥレット症候群治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トゥレット症候群治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tourette Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tourette Syndrome Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Tourette Syndrome Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tourette Syndrome Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others
Market segment by Application can be divided into
Research Center
Hospital
Clinic
Others
The key market players for global Tourette Syndrome Drug market are listed below:
Abide Therapeutics Inc
Catalyst Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Therapix Biosciences Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Tourette Syndrome Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tourette Syndrome Drug, with price, sales, revenue and global market share of Tourette Syndrome Drug from 2019 to 2021.
Chapter 3, the Tourette Syndrome Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tourette Syndrome Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Tourette Syndrome Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Tourette Syndrome Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Tourette Syndrome Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tourette Syndrome Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Tourette Syndrome Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Tourette Syndrome Drug Market Size & Forecast
1.4.1 Global Tourette Syndrome Drug Sales in Value (2016-2026))
1.4.2 Global Tourette Syndrome Drug Sales in Volume (2016-2026)
1.4.3 Global Tourette Syndrome Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Tourette Syndrome Drug Production Capacity Analysis
1.5.1 Global Tourette Syndrome Drug Total Production Capacity (2016-2026)
1.5.2 Global Tourette Syndrome Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tourette Syndrome Drug Market Drivers
1.6.2 Tourette Syndrome Drug Market Restraints
1.6.3 Tourette Syndrome Drug Trends Analysis
2 Manufacturers Profiles
2.1 Abide Therapeutics Inc
2.1.1 Abide Therapeutics Inc Details
2.1.2 Abide Therapeutics Inc Major Business
2.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Product and Services
2.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Catalyst Pharmaceuticals Inc
2.2.1 Catalyst Pharmaceuticals Inc Details
2.2.2 Catalyst Pharmaceuticals Inc Major Business
2.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
2.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Neurocrine Biosciences Inc
2.3.1 Neurocrine Biosciences Inc Details
2.3.2 Neurocrine Biosciences Inc Major Business
2.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Product and Services
2.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Psyadon Pharmaceuticals Inc
2.4.1 Psyadon Pharmaceuticals Inc Details
2.4.2 Psyadon Pharmaceuticals Inc Major Business
2.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
2.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Reviva Pharmaceuticals Inc
2.5.1 Reviva Pharmaceuticals Inc Details
2.5.2 Reviva Pharmaceuticals Inc Major Business
2.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
2.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Synchroneuron Inc
2.6.1 Synchroneuron Inc Details
2.6.2 Synchroneuron Inc Major Business
2.6.3 Synchroneuron Inc Tourette Syndrome Drug Product and Services
2.6.4 Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Teva Pharmaceutical Industries Ltd Details
2.7.2 Teva Pharmaceutical Industries Ltd Major Business
2.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Therapix Biosciences Ltd
2.8.1 Therapix Biosciences Ltd Details
2.8.2 Therapix Biosciences Ltd Major Business
2.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Product and Services
2.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Tourette Syndrome Drug Sales by Manufacturer
3.1 Global Tourette Syndrome Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Tourette Syndrome Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Tourette Syndrome Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Tourette Syndrome Drug Manufacturer Market Share
3.4.2 Top 6 Tourette Syndrome Drug Manufacturer Market Share
3.5 Global Tourette Syndrome Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Tourette Syndrome Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tourette Syndrome Drug Market Size by Region
4.1.1 Global Tourette Syndrome Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Tourette Syndrome Drug Revenue by Region (2016-2026)
4.2 North America Tourette Syndrome Drug Revenue (2016-2026)
4.3 Europe Tourette Syndrome Drug Revenue (2016-2026)
4.4 Asia-Pacific Tourette Syndrome Drug Revenue (2016-2026)
4.5 South America Tourette Syndrome Drug Revenue (2016-2026)
4.6 Middle East and Africa Tourette Syndrome Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Tourette Syndrome Drug Sales in Volume by Type (2016-2026)
5.2 Global Tourette Syndrome Drug Revenue by Type (2016-2026)
5.3 Global Tourette Syndrome Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Tourette Syndrome Drug Sales in Volume by Application (2016-2026)
6.2 Global Tourette Syndrome Drug Revenue by Application (2016-2026)
6.3 Global Tourette Syndrome Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Tourette Syndrome Drug Sales by Type (2016-2026)
7.2 North America Tourette Syndrome Drug Sales by Application (2016-2026)
7.3 North America Tourette Syndrome Drug Market Size by Country
7.3.1 North America Tourette Syndrome Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Tourette Syndrome Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Tourette Syndrome Drug Sales by Type (2016-2026)
8.2 Europe Tourette Syndrome Drug Sales by Application (2016-2026)
8.3 Europe Tourette Syndrome Drug Market Size by Country
8.3.1 Europe Tourette Syndrome Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Tourette Syndrome Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Tourette Syndrome Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Tourette Syndrome Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Tourette Syndrome Drug Market Size by Region
9.3.1 Asia-Pacific Tourette Syndrome Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Tourette Syndrome Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Tourette Syndrome Drug Sales by Type (2016-2026)
10.2 South America Tourette Syndrome Drug Sales by Application (2016-2026)
10.3 South America Tourette Syndrome Drug Market Size by Country
10.3.1 South America Tourette Syndrome Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Tourette Syndrome Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tourette Syndrome Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Tourette Syndrome Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Tourette Syndrome Drug Market Size by Country
11.3.1 Middle East & Africa Tourette Syndrome Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Tourette Syndrome Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Tourette Syndrome Drug Typical Distributors
12.3 Tourette Syndrome Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Tourette Syndrome Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Tourette Syndrome Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Abide Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 4. Abide Therapeutics Inc Major Business
Table 5. Abide Therapeutics Inc Tourette Syndrome Drug Product and Services
Table 6. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Catalyst Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Catalyst Pharmaceuticals Inc Major Business
Table 9. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 10. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Neurocrine Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 12. Neurocrine Biosciences Inc Major Business
Table 13. Neurocrine Biosciences Inc Tourette Syndrome Drug Product and Services
Table 14. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Psyadon Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 16. Psyadon Pharmaceuticals Inc Major Business
Table 17. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 18. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Reviva Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Reviva Pharmaceuticals Inc Major Business
Table 21. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 22. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Synchroneuron Inc Basic Information, Manufacturing Base and Competitors
Table 24. Synchroneuron Inc Major Business
Table 25. Synchroneuron Inc Tourette Syndrome Drug Product and Services
Table 26. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical Industries Ltd Major Business
Table 29. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product and Services
Table 30. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Therapix Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Therapix Biosciences Ltd Major Business
Table 33. Therapix Biosciences Ltd Tourette Syndrome Drug Product and Services
Table 34. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Tourette Syndrome Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Tourette Syndrome Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Tourette Syndrome Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Tourette Syndrome Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Tourette Syndrome Drug Production Site of Key Manufacturer
Table 40. Tourette Syndrome Drug New Entrant and Capacity Expansion Plans
Table 41. Tourette Syndrome Drug Mergers & Acquisitions in the Past Five Years
Table 42. Global Tourette Syndrome Drug Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Tourette Syndrome Drug Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Tourette Syndrome Drug Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Tourette Syndrome Drug Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Tourette Syndrome Drug Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Tourette Syndrome Drug Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Tourette Syndrome Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Tourette Syndrome Drug Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Tourette Syndrome Drug Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Tourette Syndrome Drug Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Tourette Syndrome Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Tourette Syndrome Drug Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Tourette Syndrome Drug Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Tourette Syndrome Drug Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Tourette Syndrome Drug Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Tourette Syndrome Drug Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Tourette Syndrome Drug Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Tourette Syndrome Drug Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Tourette Syndrome Drug Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Tourette Syndrome Drug Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Tourette Syndrome Drug Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Tourette Syndrome Drug Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Tourette Syndrome Drug Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Tourette Syndrome Drug Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Tourette Syndrome Drug Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Tourette Syndrome Drug Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Tourette Syndrome Drug Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Tourette Syndrome Drug Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Tourette Syndrome Drug Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Tourette Syndrome Drug Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Tourette Syndrome Drug Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Tourette Syndrome Drug Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Tourette Syndrome Drug Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Tourette Syndrome Drug Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Tourette Syndrome Drug Typical Distributors
Table 101. Tourette Syndrome Drug Typical Customers
List of Figures
Figure 1. Tourette Syndrome Drug Picture
Figure 2. Global Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 3. AZD-5213
Figure 4. CPP-115
Figure 5. Dutetrabenazine ER
Figure 6. Ecopipam Hydrochloride
Figure 7. Others
Figure 8. Global Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Tourette Syndrome Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Tourette Syndrome Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Tourette Syndrome Drug Sales (2016-2026) & (K Pcs)
Figure 16. Global Tourette Syndrome Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Tourette Syndrome Drug Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Tourette Syndrome Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Tourette Syndrome Drug Market Drivers
Figure 20. Tourette Syndrome Drug Market Restraints
Figure 21. Tourette Syndrome Drug Market Trends
Figure 22. Global Tourette Syndrome Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Tourette Syndrome Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Tourette Syndrome Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Tourette Syndrome Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Tourette Syndrome Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Tourette Syndrome Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Tourette Syndrome Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Tourette Syndrome Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Tourette Syndrome Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Tourette Syndrome Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Tourette Syndrome Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Tourette Syndrome Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Tourette Syndrome Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Tourette Syndrome Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Tourette Syndrome Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Tourette Syndrome Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Tourette Syndrome Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Tourette Syndrome Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Tourette Syndrome Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Tourette Syndrome Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Tourette Syndrome Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Tourette Syndrome Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Tourette Syndrome Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Tourette Syndrome Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Tourette Syndrome Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Tourette Syndrome Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Tourette Syndrome Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Tourette Syndrome Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Tourette Syndrome Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のシェーグレン症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Sicca Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の非定型溶血性尿毒症症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Atypical Hemolytic Uremic Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のゾリンジャー-エリソン症候群検査市場 2021：企業別、地域別、種類・用途別 The Zollinger - Ellison Syndrome Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のプラダーウィリー症候群治療市場 2021：企業別、地域別、種類・用途別 The Prader-Willi Syndrome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のレット症候群市場 2021：企業別、地域別、種類・用途別 The Rett Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…